U.S. Telecom Services and Carriers Stock News

NYSE:LLY
NYSE:LLYPharmaceuticals

Jaypirca Trial Win Highlights Eli Lilly’s Expanding Oncology Growth Story

Eli Lilly's Jaypirca (pirtobrutinib) achieved positive Phase 3 results in chronic lymphocytic leukemia and small lymphocytic lymphoma. The late stage trial showed that Jaypirca, combined with other therapies, improved progression free survival for patients. The data could support a regulatory submission this year to expand Jaypirca's approved uses beyond its current label. Eli Lilly (NYSE:LLY), trading at $929.55 at the last close, is widely associated with its GLP 1 obesity and diabetes...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Assessing Webull (BULL) Valuation After Zero Commission Launch And Record Revenue Update

Webull (BULL) has drawn fresh attention after Webull Canada introduced zero commission trading for U.S. and Canadian equities. This coincides with record revenue disclosures and heavier marketing spend in its latest annual report. See our latest analysis for Webull. The recent launch of zero commission trading and the latest annual report have come alongside a 1-day share price return of 7.1% and a 7-day share price return of 6.9%. However, Webull’s year to date share price return of 35.5%...
NYSE:BMY
NYSE:BMYPharmaceuticals

FDA Setback For Replimune Opdivo Combo Adds Uncertainty To BMY Outlook

The US FDA refused to file Replimune’s application for its experimental skin cancer drug in combination with Bristol Myers Squibb’s Opdivo for advanced melanoma. The decision was based on concerns about the study design rather than detailed efficacy or safety findings. This affects a collaboration that sits within Bristol Myers Squibb’s core immuno oncology efforts around NYSE:BMY’s Opdivo franchise. Bristol Myers Squibb, trading as NYSE:BMY, is a large biopharmaceutical company with a...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Credo Acquisition Of DustPhotonics Puts Optical AI Connectivity In Focus

Credo Technology Group Holding (NasdaqGS:CRDO) has entered a definitive agreement to acquire DustPhotonics, a Silicon Photonics developer focused on optical connectivity. The deal expands Credo's reach from electrical interconnects into optical solutions for AI and cloud data centers. The transaction is expected to influence future product offerings, market reach, and Credo's role in AI infrastructure connectivity. For you as an investor, this move puts NasdaqGS:CRDO directly into the...
NYSE:FDP
NYSE:FDPFood

Fresh Del Monte Produce Earnings Strength Questioned By Stagnant Sales And Margins

Fresh Del Monte Produce (NYSE:FDP) recently reported strong quarterly earnings, highlighting solid profitability in the most recent period. At the same time, the company continues to face long running revenue stagnation, a weaker revenue outlook, and structural profitability pressures. These mixed signals are raising questions about how sustainable the latest results may be without deeper business changes. Fresh Del Monte Produce, a global supplier of fresh and fresh cut fruits and...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

A Look At Palomar Holdings (PLMR) Valuation After Keefe Bruyette Woods Price Target Hike And Outperform Reaffirmation

Palomar Holdings (PLMR) is back on traders’ screens after a price target hike and reaffirmed Outperform rating from Keefe, Bruyette & Woods, a move that coincides with generally positive analyst sentiment. See our latest analysis for Palomar Holdings. Recent trading reflects that renewed optimism, with a 5.35% 7 day share price return and a 6.81% 30 day share price return, set against a year to date share price decline of 2.61% and a three year total shareholder return of 139.07%. This...
NYSE:FND
NYSE:FNDSpecialty Retail

A Look At Floor & Decor (FND) Valuation After New Portland Store Opening And Recent Share Price Weakness

Floor & Decor Holdings (FND) is drawing investor attention after opening a new warehouse store and design center in the Portland metro area, extending its footprint beyond 270 warehouse-format locations nationwide. See our latest analysis for Floor & Decor Holdings. While the new Portland warehouse highlights ongoing expansion, the share price tells a different story, with a 30 day share price return of an 11.93% decline and a 1 year total shareholder return of a 31.27% decline. This suggests...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Penguin Solutions (PENG) Is Up 20.3% After Raising 2026 Outlook Despite Revenue Decline – Has The Bull Case Changed?

In early April 2026, Penguin Solutions, Inc. reported second-quarter results showing lower revenue of US$343 million year on year but sharply higher net income of US$37.45 million and raised its full-year 2026 outlook to target 12% year over year net sales growth (plus or minus 5%) and diluted EPS of US$1.30 (plus or minus US$0.15). The company also filed employee stock ownership plan-related shelf registrations and saw several pre-planned insider stock sales, developments that contrast with...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ADMA Biologics (ADMA) Is Up 12.1% After Short-Seller Channel-Stuffing Allegations Spur Legal Scrutiny

In recent days, ADMA Biologics has come under scrutiny after a short-seller report alleged channel stuffing around its ASCENIV product, prompting multiple law firms to investigate potential securities law violations and raising questions about the quality of its reported revenues. The developments have also led at least one covering analyst to downgrade the stock, citing concerns over ADMA’s limited public response and growing receivables indicators that may signal pressure on revenue...
NYSE:COP
NYSE:COPOil and Gas

Is It Time To Reassess ConocoPhillips (COP) After Its Strong Multi Year Rally?

Wondering if ConocoPhillips at around US$123.62 offers fair value or if the market is getting ahead of itself? This breakdown helps you frame the price against fundamentals rather than just headlines. The stock has seen a 6.1% decline over the last 7 days, a 1.4% return over 30 days, and a 27.8% return year to date, with a 47.9% return over the last year and 190.4% over 5 years. Recent coverage of ConocoPhillips has focused on its role as a major US energy name and how broader energy market...
NYSE:TRNO
NYSE:TRNOIndustrial REITs

Assessing Terreno Realty (TRNO) Valuation After New Leased Miami Facility And Supreme Court Lease Renewal

Terreno Realty (TRNO) has completed Countyline Corporate Park Phase IV Building 34 in Hialeah, Florida. The 220,000 square foot facility is fully leased and is expected to achieve LEED certification. See our latest analysis for Terreno Realty. These fully leased projects in Miami and Washington, D.C. arrive as Terreno Realty’s share price trades at $65.60, with an 11.15% year to date share price return and a 21.96% 1 year total shareholder return, suggesting building momentum. If this kind of...
NYSE:WMK
NYSE:WMKConsumer Retailing

The Bull Case For Weis Markets (WMK) Could Change Following Financial Restatement And Delayed 2025 Report

In early April 2026, Weis Markets disclosed that it would restate multiple prior-year audited financial statements after discovering overstated inventory and also delay filing its 2025 annual report. The announcement has prompted law firm Bronstein, Gewirtz & Grossman, LLC to investigate potential claims on behalf of Weis Markets shareholders, spotlighting concerns about the company’s accounting controls and financial reporting reliability. We’ll now examine how the restatement of prior-year...
NYSE:VAL
NYSE:VALEnergy Services

Will Petrobras’ 1,064-Day Extension Reshape Valaris’ (VAL) Backlog Strength and Earnings Visibility Narrative?

Valaris Limited previously announced that it secured a 1,064-day contract extension with Petrobras for drillship VALARIS DS-4 offshore Brazil, expected to start in November 2027, adding about US$447 million to backlog while slightly reducing the remaining value of the current contract by roughly US$21 million due to a day-rate adjustment. Separately, Halliburton disclosed a collaboration with PETRONAS Suriname and Valaris that links subsurface evaluation, field planning, and digital well...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Critical Metals (CRML) Is Up 11.2% After Tanbreez Tests Boost Rare Earth Recoveries Above 85%

Critical Metals Corp. reported that 2025 metallurgical test work for its Tanbreez rare earths project in Greenland replicated and improved on 2016 results, delivering higher-grade TREO and HREO concentrates with recovery rates better than 85% using an upgraded magnetic separation flowsheet. This past test program, now moving into pilot plant operations planned for May 2026 with a 150-tonne bulk sample and offtake testing, marks a key step in validating Tanbreez’s processing route and...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Gravity Supply Fix And 2027 Plans Confront Steep Share Slide

Lucid Group resolved a supplier related issue that temporarily disrupted Q1 deliveries of its Gravity SUV. The company reaffirmed its full year production guidance after addressing the supply chain problem. Lucid also unveiled major updates planned for its 2027 Gravity lineup, including new technology and personalization options. For investors watching NasdaqGS:LCID, the update comes against a backdrop of steep share price declines over longer periods, including a 63.5% drop over the past...
NYSE:LOB
NYSE:LOBBanks

Why Live Oak Bancshares (LOB) Is Up 7.4% After Earnings Jump And Valuation Thesis Vindication – And What's Next

In early 2025, Live Oak Bancshares reported strong fundamental improvements, including a roughly 20% increase in revenue and around 70% growth in earnings per share, alongside continued positive analyst coverage. InvestingPro’s prior assessment that the bank was significantly undervalued gained traction as subsequent results helped validate its valuation framework and the company’s improving fundamentals. Next, we’ll examine how this earnings strength and reaffirmed analyst confidence...
NasdaqGS:BYND
NasdaqGS:BYNDFood

A Look At Beyond Meat’s Valuation After Its Nationwide Beyond Breakfast Sausage Launch

Beyond Meat (BYND) has drawn fresh attention after announcing a nationwide rollout of its Beyond Breakfast Sausage line at major retailers. This gives investors a new product launch to weigh alongside the company’s recent financial updates. See our latest analysis for Beyond Meat. The share price has reacted sharply to recent news, with a 1-day share price return of 10.63% and a 7-day return of 11.86%. However, the 1-year total shareholder return of 75.56% and the 5-year total shareholder...
NYSE:ARCO
NYSE:ARCOHospitality

A Look At Arcos Dorados Holdings’s Valuation After Recent Share Price Momentum

Arcos Dorados Holdings (NYSE:ARCO), the master franchisee for McDonald’s across Latin America and the Caribbean, has drawn investor attention after recent share price gains over the past month and the past three months. See our latest analysis for Arcos Dorados Holdings. Those recent gains build on a 30 day share price return of 11.93% and a year to date share price return of 18.38%, alongside a 1 year total shareholder return of 22.44%. Together, these figures point to strengthening momentum...
NasdaqGS:DOX
NasdaqGS:DOXIT

A Look At Amdocs (DOX) Valuation After New Institutional Stake And Shareholder-Friendly Proposals

Institutional interest and shareholder proposals come into focus Pzena Investment Management’s disclosure of an 11.3% stake in Amdocs (NasdaqGS:DOX), alongside proposals for a higher quarterly dividend and an expanded Employee Share Purchase Plan, has drawn fresh attention to the stock’s current setup for shareholders. See our latest analysis for Amdocs. At a share price of US$64.94, Amdocs has seen a 3.1% 1 day share price return but a 21.6% 90 day share price return decline, while the 1...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

What Scholar Rock Holding (SRRK)'s FDA-Aligned Apitegromab BLA Resubmission Means For Shareholders

In late March 2026, Scholar Rock announced it had resubmitted its Biologics License Application to the FDA for apitegromab in spinal muscular atrophy, incorporating both the Catalent Indiana facility and a second U.S.-based fill-finish site in line with recent agency guidance. This resubmission, following a prior Complete Response Letter tied to manufacturing inspections rather than apitegromab itself, shifts regulatory focus back to the drug’s clinical profile and supply-chain readiness...
NYSE:CRM
NYSE:CRMSoftware

Salesforce AI Jobs Reshuffle Tests Support Quality And Long Term Investor Confidence

Salesforce last year announced a large scale workforce reduction in its support organization, with AI now handling roughly half of support conversations. The company directly linked the cut and redeployment of thousands of roles to the rollout of AI tools across core customer support workflows. This marks a major operational shift for Salesforce and is sparking debate about how enterprise software adoption of AI affects real jobs and service quality.
NYSE:DOV
NYSE:DOVMachinery

Is Dover (DOV) Quietly Recasting Its Industrial Identity Around CO₂ Heat Pumps And New Credit?

Earlier this month, Dover Corporation entered into a new US$1,500 million five-year unsecured revolving credit facility and, through Advansor, launched the SteelXL Heat Pump, a high-capacity CO₂ system aimed at food processing, district heating, and large commercial buildings. The SteelXL Heat Pump’s industrial-scale capacity and regulatory-friendly CO₂ technology highlight Dover’s push into lower-emission thermal solutions for large HVAC and process-heating users. We’ll now examine how this...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

What Ionis Pharmaceuticals (IONS)'s Renewed Analyst Focus on Tryngolza Means For Shareholders

In the past few days, Raymond James analyst Tiago Fauth renewed coverage on Ionis Pharmaceuticals with an Outperform rating, highlighting an improved outlook anchored by the RNA-based drug Tryngolza for severe hypertriglyceridemia. This latest endorsement underscores how Tryngolza, already central to Ionis’ expansion into larger patient groups, is increasingly viewed as a key pillar of its RNA medicines portfolio despite ongoing profitability and insider selling concerns. Now we’ll examine...
NYSE:ECVT
NYSE:ECVTChemicals

Ecovyst (ECVT) Is Up 9.1% After Earnings Beat And 2026 EPS Guidance Update Has The Bull Case Changed?

Ecovyst recently reported quarterly earnings that came in ahead of analyst expectations and issued full-year 2026 EPS guidance in the US$0.45–US$0.65 range, prompting several brokerages to reaffirm or upgrade their views on the company’s outlook. This combination of an earnings beat and clearer profit guidance has sharpened the focus on how Ecovyst’s fundamentals align with assessments that its shares may be trading at a premium to intrinsic value. We’ll now explore how Ecovyst’s...